Cargando…

Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson’s disease

Parkinson’s disease (PD) is the second most popular age-associated neurodegenerative disorder after Alzheimer’s disease. The degeneration of dopaminergic neurons, aggregation of α-synuclein (α-syn), and locomotor defects are the main characteristic features of PD. The main cause of a familial form o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asthana, Jyotsna, Shravage, Bhupendra V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632658/ https://www.ncbi.nlm.nih.gov/pubmed/36337696 http://dx.doi.org/10.3389/fnagi.2022.986849

Ejemplares similares

Roles of microglial mitophagy in neurological disorders
por: Liu, Yang, et al.
Publicado: (2022)

Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications
por: Gao, Fei, et al.
Publicado: (2017)

Exploring brain changes of impulse control disorders in Parkinson's disease: An ALE study
por: Gu, Lihua, et al.
Publicado: (2022)

Regulation of Mitophagy by Sirtuin Family Proteins: A Vital Role in Aging and Age-Related Diseases
por: Wan, Wei, et al.
Publicado: (2022)

A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
por: Chen, Huiyi, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 Modulates Microglial Polarization That Attenuates Neurodegeneration in Mice and Cellular Models of Parkinson's Disease
por: Yang, Changwei, et al.
Publicado: (2021)

Editorial: Exploring the role of exosomes in disease progression and therapeutics in neurodegeneration
por: Jan, Arif Tasleem, et al.
Publicado: (2023)

Impact of aging on animal models of Parkinson's disease
por: Klæstrup, Ida Hyllen, et al.
Publicado: (2022)

Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease: Pathogenesis and Therapeutic Implications
por: Zheng, Wei, et al.
Publicado: (2022)

Pooled analysis of frontal lobe transcriptomic data identifies key mitophagy gene changes in Alzheimer's disease brain
por: Mei, Taoyu, et al.
Publicado: (2023)

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms
por: Li, Dan-ning, et al.
Publicado: (2022)

Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment
por: Eker, Furkan, et al.
Publicado: (2023)

Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases
por: Gao, Panyue, et al.
Publicado: (2021)

Mitochondrial Morphology and Mitophagy in Heart Diseases: Qualitative and Quantitative Analyses Using Transmission Electron Microscopy
por: Collins, Helen E., et al.
Publicado: (2021)

Modeling of cerebellar transcranial electrical stimulation effects on hand tremor in Parkinson’s disease
por: Rahimi, Soraya, et al.
Publicado: (2023)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Scalp Acupuncture Attenuates Brain Damage After Intracerebral Hemorrhage Through Enhanced Mitophagy and Reduced Apoptosis in Rats
por: Liu, Peng, et al.
Publicado: (2021)

Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
por: Dou, Kaixin, et al.
Publicado: (2022)

Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
por: Sano, Hiromi, et al.
Publicado: (2023)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
por: Wang, Qinqin, et al.
Publicado: (2021)

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023)

The role of microglial autophagy in Parkinson’s disease
por: Zhu, Rui, et al.
Publicado: (2022)

The Disease Modification Conundrum in Parkinson’s Disease: Failures and Hopes
por: Mari, Zoltan, et al.
Publicado: (2022)

Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models
por: Zou, Cuihua, et al.
Publicado: (2023)

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson’s Disease-Related Depression: Profile and Proposal
por: Mou, Ya-Kui, et al.
Publicado: (2022)

Editorial: Advancing the treatment landscape in Parkinson's disease using sensor technology and data-driven modeling
por: Ramdhani, Ritesh A., et al.
Publicado: (2022)

Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson’s disease model
por: Sancandi, Marco, et al.
Publicado: (2023)

Editorial: The Neurovascular Unit as a Potential Biomarker and Therapeutic Target in Cerebrovascular Disease
por: Nizari, Shereen, et al.
Publicado: (2022)

Serum zinc deficiency is a potential risk factor for the occurrence of levodopa-induced dyskinesia in drug-naïve Parkinson’s disease
por: Kim, Joung Eun, et al.
Publicado: (2023)

Editorial: Genetic and molecular diversity in Parkinson's disease
por: Abdul Murad, Nor Azian, et al.
Publicado: (2022)

Oculomotor impairments in de novo Parkinson’s disease
por: Zhou, Meng-Xi, et al.
Publicado: (2022)

Precision medicine for Parkinson’s disease: The subtyping challenge
por: Frasier, Mark, et al.
Publicado: (2022)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Editorial: Advances in neural reprogramming, disease modeling and therapeutic insights
por: Lau, Shong, et al.
Publicado: (2023)

Machine Learning Models for Diagnosis of Parkinson’s Disease Using Multiple Structural Magnetic Resonance Imaging Features
por: Ya, Yang, et al.
Publicado: (2022)

Corrigendum: Experimental Models of Cognitive Impairment for Use in Parkinson's Disease Research: The Distance Between Reality and Ideal
por: Fan, Yaohua, et al.
Publicado: (2021)

Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential
por: Chen, Yanting, et al.
Publicado: (2023)

Peripheral Clock System Abnormalities in Patients With Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2021)

New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease
por: Xu, Jianli, et al.
Publicado: (2022)

Genetic analysis of dystonia-related genes in Parkinson's disease
por: Wang, Yige, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9it2bhpa4ohfc39ednc35rf8en